Technical Analysis of Indian Equities by Nooresh

Nifty Pharma Index–Can it breakout ?

Nifty Pharma blog

Nifty Pharma – Back to the resistance of 8300-8400.

Will it be able to breakout. Will be on radar for coming few weeks.

The Top 2 weights

Sun Pharma – ( 23% Weight )

Sun Pharma


Dr Reddys – ( 17% Weight )

Dr Reddys blog



The Indian Trading Conclave goes live tomorrow - Speaking on a difficult topic but apt for current markets - Identifying Bottom & Breakout Formations.…


Whatsapp Subscription to the Blog

As most of us now prefer to read/save articles/post through the mobile phone and whatsapp, we are also drifting towards whatsapp subscription to the blog.
This is free and what do you get

1) In this you will get an alert on whatsapp whenever a new article is posted on the website.

2) Interesting older articles from

3) Interesting links and reads from Analyse India

4) Technical Charts and more updates in your whatsapp

The frequency would be a few messages a week. Generally less than 7-10 in a week or 1-2 in a day.

Click on this link for Whatsapp Subscription -

Do save 7977801488 in your contacts to receive the updates.

or whatsapp subscribe to +91 79778 01488 to receive messages save the number in your contacts.
Those who would like to shift to whatsapp can unsubscribe from the email list.

For more about our ADVISORY SERVICES

Customized Advisory Services-

Derivatives -

DISCLOSURE Nooresh Merani

Securities covered above:  All mentioned in the above post

SEBI Registration disclosure - Investment Adviser ( INA000002991)

Financial Interest:

Nooresh Merani and his family/associates/ analysts would have exposure in the securities mentioned in the above report/article.

Nooresh Merani and his family/associates/ analysts do not have any financial interest/beneficial ownership of more than 1% in the company covered by Analyst.

Nooresh Merani and his family/associates/ analysts have not received any compensation from the company/third party covered in the above report/article ever.

Nooresh Merani and his family/associates/ analysts  has not served as an officer, director or employee of company covered in the report/article and has not been engaged in market-making activity of the company covered in the report/article.

The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision

Article by Nooresh Merani

Nooresh has written 2753 articles.

You can follow Nooresh Tech on Facebook and Twitter here.

{ 0 comments… add one }

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.